BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3146695)

  • 21. Immunogenic and antigenic epitopes of immunoglobulins--VII. The topographical distribution of Fc gamma epitopes and the relationship of an iso-allotypic specificity to the presence of histidine 435.
    Nik Jaafar MI; Lowe JA; Ling NR; Jefferis R
    Mol Immunol; 1984 Feb; 21(2):137-43. PubMed ID: 6200772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice.
    Theofilopoulos AN; Balderas RS; Hang L; Dixon FJ
    J Exp Med; 1983 Sep; 158(3):901-19. PubMed ID: 6224885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of human B cell differentiation by Fc region activators. II. Stimulation of IL-6 production.
    Morgan EL; Hobbs MV; Thoman ML; Janda J; Noonan DJ; Kadar J; Weigle WO
    J Immunol; 1990 Apr; 144(7):2499-505. PubMed ID: 2319130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allotypic and isotypic specificities of rabbit IgM: localization to the Fab mu or Fc mu fragments.
    Gilman-Sachs A; Dray S
    Mol Immunol; 1985 Jan; 22(1):57-65. PubMed ID: 2579327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hinge-Deficient IgG1 Fc Fusion: Application to Human Lactoferrin.
    Shiga Y; Murata D; Sugimoto A; Oshima Y; Tada M; Ishii-Watabe A; Imai K; Tomii K; Takeuchi T; Kagaya S; Sato A
    Mol Pharm; 2017 Sep; 14(9):3025-3035. PubMed ID: 28763236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystals of the human heavy chain disease protein Riv and human Fc fragment are isomorphous: further evidence for conformational flexibility in the hinge region of immunoglobulins.
    Mariuzza RA; Poljak RJ; Mihaesco C; Mihaesco E
    J Mol Biol; 1983 Apr; 165(3):559-61. PubMed ID: 6405046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoglobulin heavy chain constant regions regulate immunity and tolerance to idiotypes of antibody variable regions.
    Reitan SK; Hannestad K
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7588-93. PubMed ID: 12032327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional mapping of the Fc gamma RII binding site on human IgG1 by synthetic peptides.
    Medgyesi D; Uray K; Sallai K; Hudecz F; Koncz G; Abramson J; Pecht I; Sármay G; Gergely J
    Eur J Immunol; 2004 Apr; 34(4):1127-35. PubMed ID: 15048724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
    Quast I; Keller CW; Maurer MA; Giddens JP; Tackenberg B; Wang LX; Münz C; Nimmerjahn F; Dalakas MC; Lünemann JD
    J Clin Invest; 2015 Nov; 125(11):4160-70. PubMed ID: 26436649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new case of gamma-3 heavy chain disease. Biochemical and immunological investigations.
    Biewenga J; van Loghem E
    Vox Sang; 1979; 36(4):193-8. PubMed ID: 88813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An explorative study towards the chemical synthesis of the immunoglobulin G1 Fc CH3 domain.
    Grassi L; Roschger C; Stanojlović V; Cabrele C
    J Pept Sci; 2018 Dec; 24(12):e3126. PubMed ID: 30346065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of synthetic gamma-chain peptides in the localization of the binding site(s) on human IgG1 for the Fc receptors of homologous monocytes and heterologous mouse macrophages.
    Ratcliffe A; Stanworth DR
    Immunol Lett; 1982 Apr; 4(4):215-21. PubMed ID: 6212539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to the first constant-region domain of the murine mu-chain induced by a synthetic peptide.
    Ghose AC; Karush F
    Mol Immunol; 1985 Oct; 22(10):1145-50. PubMed ID: 3935914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin heavy-chain-associated amyloidosis.
    Eulitz M; Weiss DT; Solomon A
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6542-6. PubMed ID: 2118650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interaction of synthetic decapeptide SLTCLVKGFY with human T lymphocytes].
    Navolotskaia EV; Malkova NV; Lepikhova TN; Krasnova SB; Zargarova TA; Zav'ialov VP; Lipkin VM
    Bioorg Khim; 2001; 27(5):359-63. PubMed ID: 11641910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants recognized by murine rheumatoid factors: molecular localization using a panel of mouse myeloma variant immunoglobulins.
    Stassin V; Coulie PG; Birshtein BK; Secher DS; Van Snick J
    J Exp Med; 1983 Nov; 158(5):1763-8. PubMed ID: 6195294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uptake of recombinant myeloperoxidase, free or fused to Fc gamma, by macrophages enhances killing activity toward micro-organisms.
    Tournay C; Courtoy PJ; Marodi L; Totté P; Werenne J; Jacquet A; Garcia-Quintana L; Bollen A; Moguilevsky N
    DNA Cell Biol; 1996 Aug; 15(8):617-24. PubMed ID: 8769563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystallographic structural studies of a human Fc fragment. II. A complete model based on a Fourier map at 3.5 A resolution.
    Deisenhofer J; Colman PM; Epp O; Huber R
    Hoppe Seylers Z Physiol Chem; 1976 Dec; 357(10):1421-34. PubMed ID: 992566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A transcriptional defect underlies B lymphocyte dysfunction in a patient diagnosed with non-X-linked hyper-IgM syndrome.
    Bhushan A; Barnhart B; Shone S; Song C; Covey LR
    J Immunol; 2000 Mar; 164(6):2871-80. PubMed ID: 10706672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.